ROM Technologies, Inc.

ROM Technologies, Inc. has been granted 111 US utility patents between 2020 and 2025, placing ROM Technologies, Inc. at rank #3,356 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 21.2 claims per patent with primary concentration in G16H (HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA). As a US Corporation, ROM Technologies, Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 64.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Historical data spans 2020 through 2025, with 111 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. ROM Technologies, Inc.'s 21.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark ROM Technologies, Inc. against peers pursuing similar technology classes.